Stockreport

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions [Yahoo! Finance]

FibroGen, Inc  (FGEN) 
Last fibrogen, inc earnings: 3/2 04:01 pm Check Earnings Report
PDF Roxadustat Net Product Revenue in China: $46.2 million in Q3 2024, a 57% increase from $29.4 million in Q3 2023. Total Roxadustat Net Sales in China: $96.6 million in [Read more]